IDO in Human Gut Graft-versus-Host Disease

Slides:



Advertisements
Similar presentations
The Complex Relationship between Human Herpesvirus 6 and Acute Graft-versus-Host Disease  Claire Pichereau, Kristell Desseaux, Anne Janin, Catherine Scieux,
Advertisements

Increase in FOXP3+ Regulatory T Cells in GVHD Skin Biopsies Is Associated with Lower Disease Severity and Treatment Response  Cristina Fondi, Chiara Nozzoli,
In Situ Detection of HY-Specific T Cells in Acute Graft-versus-Host Disease–Affected Male Skin after Sex-Mismatched Stem Cell Transplantation  Yeung-Hyen.
Mismatch on Glutathione S-Transferase T1 Increases the Risk of Graft-versus-Host Disease and Mortality after Allogeneic Stem Cell Transplantation  María.
GLCCI1 and Glucocorticoid Receptor Genetic Diversity and Response to Glucocorticoid-Based Treatment of Graft-versus-Host Disease  Alix O'Meara, Wahid.
Successful Remission Rates and Survival after Lymphodepleting Chemotherapy and Donor Lymphocyte Infusion for Relapsed Hematologic Malignancies Postallogeneic.
In Stem Cell Transplantation by Limiting the Morbidity of Graft-versus-Host Disease Tolerance to Myeloablative Conditioning is Improved  Nicolas Novitzky,
How to Treat MDS without Stem Cell Transplantation
Frequent Detection of Herpes Simplex Virus Antigen in Skin and Peripheral Blood CD34+ Mononuclear Cells from Patients with Graft-versus-Host Disease 
High-Content Flow Cytometry and Temporal Data Analysis for Defining a Cellular Signature of Graft-Versus-Host Disease  Ryan Remy Brinkman, Maura Gasparetto,
Vaccination of Children following Allogeneic Stem Cell Transplantation
Mark A. Schroeder, Jaebok Choi, Karl Staser, John F. DiPersio 
David Myerson, Gideon Steinbach, Ted A. Gooley, Howard M. Shulman 
IL-12hi Rapamycin-Conditioned Dendritic Cells Mediate IFN-γ-Dependent and Fas- Supported Apoptosis of Alloreactive CD4+ T Cells and Inhibit Graft-Versus-Host.
Sympathectomy Protects Denervated Skin from Graft-Versus-Host Disease
Spontaneous Autologous Graft-versus-Host Disease in Plasma Cell Myeloma Autograft Recipients: Flow Cytometric Analysis of Hematopoietic Progenitor Cell.
Busulfan, Fludarabine, and Alemtuzumab As a Reduced Toxicity Regimen for Children with Malignant and Nonmalignant Diseases Improves Engraftment and Graft-versus-
Yngvar Fløisand, Knut E. A
A Phase II Study of Bortezomib Plus Prednisone for Initial Therapy of Chronic Graft- versus-Host Disease  Alex F. Herrera, Haesook T. Kim, Bhavjot Bindra,
B Cells in Chronic Graft-versus-Host Disease
Late Acute Graft-versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation  Aazim K. Omer, Daniel J. Weisdorf, Aleksandr Lazaryan,
Sabina Kersting, Leo F. Verdonck 
Genital Chronic Graft-versus-Host Disease in Females: A Cross-Sectional Study  Eva Smith Knutsson, Yvonne Björk, Anna-Karin Broman, Lotti Helström, Anne-Marie.
A Genetic Modifier of the Gut Microbiome Influences the Risk of Graft-versus-Host Disease and Bacteremia After Hematopoietic Stem Cell Transplantation 
Therapeutic Benefit of Bortezomib on Acute Graft-versus-Host Disease Is Tissue Specific and Is Associated with Interleukin-6 Levels  Chien-Chun Steven.
Musculoskeletal, Neurologic, and Cardiopulmonary Aspects of Physical Rehabilitation in Patients with Chronic Graft-versus-Host Disease  Sean Robinson.
Histologic Features of the Liver Biopsy Predict the Clinical Outcome for Patients with Graft-versus-Host Disease of the Liver  Rafael F. Duarte, Julio.
A Comparison of the Kinetics of Nucleated Cells and CD34+ Cells in Neonatal Peripheral Blood and Cord Blood  Joong-Pyo Kim, Young-Ho Lee, Young-Ah Lee,
Impact of Ocular Chronic Graft-versus-Host Disease on Quality of Life
Lisa A. Palmer, George E. Sale, John I
The Complex Relationship between Human Herpesvirus 6 and Acute Graft-versus-Host Disease  Claire Pichereau, Kristell Desseaux, Anne Janin, Catherine Scieux,
Cytomegalovirus Infection after Allogeneic Transplantation: Comparison of Cord Blood with Peripheral Blood and Marrow Graft Sources  Christopher M. Walker,
Claudio G. Brunstein, Bruce R. Blazar, Jeffrey S
Lymphocyte Phenotype during Therapy for Acute Graft-versus-Host Disease: A Brief Report from BMT-CTN 0302  Javier Bolaños-Meade, Juan Wu, Brent R. Logan,
Role of the Mycobiome in Human Acute Graft-versus-Host Disease
Higher Dose of Mycophenolate Mofetil Reduces Acute Graft-versus-Host Disease in Reduced-Intensity Conditioning Double Umbilical Cord Blood Transplantation 
Risk Factors and Outcome of Chronic Graft-versus-Host Disease after Allogeneic Stem Cell Transplantation—Results from a Single-Center Observational Study 
Immunologic Resolution of Human Chronic Graft-versus-Host Disease
Helicobacter pylori Infection and Graft-versus-Host Disease
The Expression of Th17-Associated Cytokines in Human Acute Graft-versus-Host Disease  Yuejun Liu, Yifeng Cai, Lan Dai, Guanghua Chen, Xiao Ma, Ying Wang,
Correlation between the numbers of naive T cells infused with blood stem cell allografts and the counts of naive T cells after transplantation  Jan Storek,
Prevention of Graft-versus-Host Disease by Adoptive T Regulatory Therapy Is Associated with Active Repression of Peripheral Blood Toll-Like Receptor 5.
B Cells and Transplantation: An Educational Resource
Prospective grading of graft-versus-host disease after unrelated donor marrow transplantation: a grading algorithm versus blinded expert panel review 
A Novel Soluble Form of Tim-3 Associated with Severe Graft-versus-Host Disease  John A. Hansen, Samir M. Hanash, Laura Tabellini, Chris Baik, Richard L.
Post-Transplantation B Cell Activating Factor and B Cell Recovery before Onset of Chronic Graft-versus-Host Disease  Caron A. Jacobson, Lixian Sun, Haesook.
Persistence of host dendritic cells after transplantation is associated with graft-versus- host disease  Geoffrey W. Chan, Gullu Gorgun, Kenneth B. Miller,
Protective Immunity Transferred by Infusion of Cytomegalovirus-Specific CD8+ T Cells within Donor Grafts: Its Associations with Cytomegalovirus Reactivation.
Possible Association between Obesity and Posttransplantation Complications Including Infectious Diseases and Acute Graft-versus-Host Disease  Shigeo Fuji,
Brile Chung, Eric Dudl, Akira Toyama, Lora Barsky, Kenneth I. Weinberg 
CD3+/Tregs Ratio in Donor Grafts Is Linked to Acute Graft-versus-Host Disease and Immunologic Recovery after Allogeneic Peripheral Blood Stem Cell Transplantation 
Regression Models for Hazard Rates Versus Cumulative Incidence Probabilities in Hematopoietic Cell Transplantation Data  Brent R. Logan, Mei-Jie Zhang,
Gerard Socié, K. Scott Baker, Smita Bhatia 
Diarrhea during the Conditioning Regimen Is Correlated with the Occurrence of Severe Acute Graft-versus-Host Disease through Systemic Release of Inflammatory.
Pharmacodynamic Monitoring Predicts Outcomes of CCR5 Blockade as Graft-versus- Host Disease Prophylaxis  Austin P. Huffman, Lee P. Richman, Lisa Crisalli,
Content Validity of the Lee Chronic Graft-versus-Host Disease Symptom Scale as Assessed by Cognitive Interviews  Emily C. Merkel, Sandra A. Mitchell,
Unrelated Stem Cell Transplantation after a Reduced Intensity Conditioning Regimen Containing High-Dose Thymoglobulin Leads to Controllable Graft-versus-Host.
John E. Levine, Sophie Paczesny, Stefanie Sarantopoulos 
Blood and Marrow Transplant Handbook
Therapeutic Immunosuppression Concentrations on Day 0 and the Development of Acute Graft Versus Host Disease (GVHD) in Hematopoietic Stem Cell Transplantation.
Young Female Donors Do Not Increase the Risk of Graft-versus-Host Disease or Impact Overall Outcomes in Pediatric HLA-Matched Sibling Hematopoietic Stem.
A Bortezomib-Based Regimen Offers Promising Survival and Graft-versus-Host Disease Prophylaxis in Myeloablative HLA-Mismatched and Unrelated Donor Transplantation:
Low Serum Levels of Total Rabbit-IgG Is Associated with Acute Graft-Versus-Host Disease after Unrelated Donor Hematopoietic Stem Cell Transplantation:
Varicella-Zoster Virus Disease Is More Frequent after Cord Blood Than after Bone Marrow Transplantation  Kristel Vandenbosch, Philippe Ovetchkine, Martin.
Alveolar Hemorrhage and Acute Graft-versus-Host Disease
Mammen Chandy  Biology of Blood and Marrow Transplantation 
Treatment versus Transplant for Challenging Hematologic Disorders
Prospective Monitoring of Tumor Necrosis Factor α and Interferon γ to Predict the Onset of Acute and Chronic Graft-versus-Host Disease after Allogeneic.
Mary Eapen  Biology of Blood and Marrow Transplantation 
Sirolimus and Mycophenolate Mofetil as Calcineurin Inhibitor–Free Graft-versus-Host Disease Prophylaxis for Reduced-Intensity Conditioning Umbilical Cord.
Presentation transcript:

IDO in Human Gut Graft-versus-Host Disease Philippe Ratajczak, Anne Janin, Régis Peffault de Larour, Lisa Koch, Brigitte Roche, David Munn, Bruce R. Blazar, Gérard Socié  Biology of Blood and Marrow Transplantation  Volume 18, Issue 1, Pages 150-155 (January 2012) DOI: 10.1016/j.bbmt.2011.08.002 Copyright © 2012 American Society for Blood and Marrow Transplantation Terms and Conditions

Figure 1 IDO distribution and expression in gut biopsies of transplanted patients without GVHD and with mild and severe GVHD. Control: nontransplanted patients infected by Helicobacter pylori. (A) Upper panel: IDO expressing cells were more numerous in patients without GVHD or with grade 2 GVHD than in patients with Grade 3 GVHD. Lower panel, specificity control: preincubation of the antibody directed against IDO with the corresponding blocking peptide resulted in absence of staining. (B) Double-positive IDO (red)/CD4 (green) cells are absent in biopsies with Helicobacter pylori, present in transplanted patients without GVHD, and are more numerous in transplanted patients with grade 2 GVHD than with grade 3 GVHD. Biology of Blood and Marrow Transplantation 2012 18, 150-155DOI: (10.1016/j.bbmt.2011.08.002) Copyright © 2012 American Society for Blood and Marrow Transplantation Terms and Conditions

Figure 2 IDO expression in gut biopsies in macrophages, dendritic, and T cells. (A) Double-positive IDO (red)/CD68 (green) cells are absent in biopsies with Helicobacter pylori, present in transplanted patients without GVHD, and are more numerous in transplanted patients with histologic GVHD. (B) Upper panel: double-positive IDO (red)/CD3 (green) cells are more numerous in transplanted patients with histologic grade 2 GVHD than with grade 3. Lower panel: double-positive IDO (red)/CD123 (green) cells are few in transplanted patients whatever the histologic GVHD grade. Biology of Blood and Marrow Transplantation 2012 18, 150-155DOI: (10.1016/j.bbmt.2011.08.002) Copyright © 2012 American Society for Blood and Marrow Transplantation Terms and Conditions

Figure 3 Counts of inflammatory cells. (A) In control biopsies with Helicobacter pylori, macrophages are prominent and some of them express IDO. In transplanted patients, T lymphocytes are prominent; among them, CD4 T lymphocytes expressing IDO are predominant in patients with grade 2 GVHD, whereas Tregs are predominant in patients with grade 3 GVHD. The highest numbers of Th17-positive cells are found in transplanted patients with grade 0 to 1 GVHD. (B) Statistical analysis for CD4/IDO double-positive cells in transplanted patients within the indicated histologic GVHD grade (n = 20); Left, no significant correlation between the proportion of CD4/Foxp3 and CD4/IDO lymphocytes; Right, positive correlation (P < .05) between the proportion of CD4/IL-17 and CD4/IDO lymphocytes. (C) Analysis of CD4 cell subpopulations and epithelial cells expressing IDO after automated count; the proportion of CD4/Foxp3 cells is significantly higher in grade 2 and grade 3 to 4 GVHD when compared with grade 0 to 1 GVHD. The proportion of CD4/IDO cells is significantly higher in grade 2 GVHD when compared with grade 3 to 4 GVHD. A significant decrease was also found for the proportion of CD4/IL-17 lymphocytes and the histologic grade of GVHD. The number of epithelial cells expressing IDO increases significantly with the grade of GVHD (ie, grade 0-1 versus grade 2 versus grade 3-4 GVHD). Epithelial cells expressing IDO are significantly numerous in the Helicobacter pylori group compared with grade 0 to 1 GVHD but significantly lower compared with grade 2 or grade 3 to 4 GVHD. Biology of Blood and Marrow Transplantation 2012 18, 150-155DOI: (10.1016/j.bbmt.2011.08.002) Copyright © 2012 American Society for Blood and Marrow Transplantation Terms and Conditions